Open AccessViral suppression is associated with HIV-antibody level and HIV-1 DNA detectability in early treated children at 2 years of age
Author(s) -
Kirsten A. Veldsman,
Barbara Laughton,
André Janse van Rensburg,
Peter Zuidewind,
Els Dobbels,
Shaun Barnabas,
Samantha Fry,
Mark F. Cotton,
Gert U. van Zyl
Publication year - 2021
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0000000000002861
Subject(s) - medicine , viremia , nevirapine , interquartile range , antibody , immunology , viral load , virology , human immunodeficiency virus (hiv) , zidovudine , cohort , pediatrics , antiretroviral therapy , viral disease
Early infant HIV diagnosis and antiretroviral therapy (ART) initiation are now implemented shortly after birth. Maintaining and monitoring ART adherence is difficult and requires frequent visits. We, therefore, investigated whether HIV antibodies and HIV-1 DNA levels are markers of cumulative viremia.